Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
lethal interactions as new therapeutic strategies for tumours defective in DNA repair or epigenetic processes. Our team closely collaborates with the Drug Development Department and the sarcoma committee
-
eligibility, please visit: http://uhr.rutgers.edu/benefits/benefits-overview . Position Status Part Time Working Hours Standard Hours 35.00 Daily Work Shift Day Work Arrangement Union Description Hourly
-
or perhaps epigenetic changes. This project will investigate the phenomenon using the rice blast fungus Magnaporthe (Syn. Pyricularia) oryzae, which destroys enough rice each year to feed 60 million people
-
scientific diver credentials such as AAUS certification. Additional assets include experience with other omics approaches or epigenetics, advanced coding skills in R or Python, and prior supervisory experience
-
which viruses hijack chromatin. Due to the major advancement in sequencing technologies and the expansion of the field of epigenetics, exploiting viruses to investigate chromatin biology has enormous
-
Position as Computational Analyst / Bioinformatician in RNA Therapeutics and Cardiometabolic Disease
. Access to HPC (https://escience.sdu.dk/index.php/ucloud ) and extensive bulk / sc / sp omic datasets. A unique position working at the intersection of microRNA and mRNA target discovery and innovation
-
McGill University | Winnipeg Sargent Park Daniel McIntyre Inkster SE, Manitoba | Canada | 2 months ago
: Department of Pharmacology & Therapeutics Course Title and Course Number: Epigenetic Drugs and Targets - PHAR 565 Estimated Number of Positions: 1 Total Hours of Work per Term: 45 hours per position Position
-
(especially targeting epigenetic changes such as CRISPR–Cas9 fused with DNMT3A or TET), normally including sufficient postdoctoral experience in that field, appropriate to an early career researcher. Skills
-
Position as Computational Analyst / Bioinformatician in RNA Therapeutics and Cardiometabolic Disease
academic partners. Access to HPC (https://escience.sdu.dk/index.php/ucloud ) and extensive bulk / sc / sp omic datasets. A unique position working at the intersection of microRNA and mRNA target discovery
-
Heidelberg). The work of our research group (http://lab.mueller-tidow.de ) focuses on stem cells and therapy resistance. We aim to understand how epigenetic dysregulation participates in the pathogenesis and